
Anabiosi-Data makes cancer therapy more tailored and effective using AI. They build AI and ML software for prognosis, diagnosis, and therapy, with Prognostic and LabFlow on a cloud-based platform. The company combines in vivo experiments and patient data from clinical partners to train models. Key technologies include AI, machine learning, LLMs, Python, deep learning, PCA, clustering, ROC analysis, and HPC. Their SaaS offerings target healthcare providers and researchers, aiming to standardize personalized cancer therapy.

Anabiosi-Data makes cancer therapy more tailored and effective using AI. They build AI and ML software for prognosis, diagnosis, and therapy, with Prognostic and LabFlow on a cloud-based platform. The company combines in vivo experiments and patient data from clinical partners to train models. Key technologies include AI, machine learning, LLMs, Python, deep learning, PCA, clustering, ROC analysis, and HPC. Their SaaS offerings target healthcare providers and researchers, aiming to standardize personalized cancer therapy.